Article
CREB3 protein family: the promising therapeutic targets for cardiovascular and metabolic diseases
25 Nov 2024
Abstract excerpt
Significant advancements in cardiovascular and metabolic disease research have been made with the CREB3 protein family. Studies have revealed that members of this family are crucial in the development of these diseases, contributing to the regulation of lipid metabolism, inflammation, and vascular function. These studies provide useful information for future therapeutic strategies in cardiovascular and metabolic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
